Works matching IS 19466234 AND DT 2018 AND VI 10 AND IP 450

Results: 4
    1
    2

    MHC proteins confer differential sensitivity to CTLA-4 and PD-1 blockade in untreated metastatic melanoma.

    Published in:
    Science Translational Medicine, 2018, v. 10, n. 450, p. 1, doi. 10.1126/scitranslmed.aar3342
    By:
    • Rodig, Scott J.;
    • Gusenleitner, Daniel;
    • Jackson, Donald G.;
    • Gjini, Evisa;
    • Giobbie-Hurder, Anita;
    • Jin, Chelsea;
    • Chang, Han;
    • Lovitch, Scott B.;
    • Horak, Christine;
    • Weber, Jeffrey S.;
    • Weirather, Jason L.;
    • Wolchok, Jedd D.;
    • Postow, Michael A.;
    • Pavlick, Anna C.;
    • Chesney, Jason;
    • Hodi, F. Stephen
    Publication type:
    Article
    3

    PP2A inhibition is a druggable MEK inhibitor resistance mechanism in KRAS-mutant lung cancer cells.

    Published in:
    Science Translational Medicine, 2018, v. 10, n. 450, p. 1, doi. 10.1126/scitranslmed.aaq1093
    By:
    • Kauko, Otto;
    • O'Connor, Caitlin M.;
    • Kulesskiy, Evgeny;
    • Sangodkar, Jaya;
    • Aakula, Anna;
    • Izadmehr, Sudeh;
    • Yetukuri, Laxman;
    • Yadav, Bhagwan;
    • Padzik, Artur;
    • Laajala, Teemu Daniel;
    • Haapaniemi, Pekka;
    • Momeny, Majid;
    • Varila, Taru;
    • Ohlmeyer, Michael;
    • Aittokallio, Tero;
    • Wennerberg, Krister;
    • Narla, Goutham;
    • Westermarck, Jukka
    Publication type:
    Article
    4

    Antibody blockade of IL-15 signaling has the potential to durably reverse vitiligo.

    Published in:
    Science Translational Medicine, 2018, v. 10, n. 450, p. 1, doi. 10.1126/scitranslmed.aam7710
    By:
    • Richmond, Jillian M.;
    • Strassner, James P.;
    • Zapata, Lucio;
    • Garg, Madhuri;
    • Riding, Rebecca L.;
    • Refat, Maggi A.;
    • Fan, Xueli;
    • Azzolino, Vincent;
    • Tovar-Garza, Andrea;
    • Tsurushita, Naoya;
    • Pandya, Amit G.;
    • Tso, J. Yun;
    • Harris, John E.
    Publication type:
    Article